In this episode of BioTalk from BioTechniques, Gal Almogy, a post-doc at ETH Zürich explains how increasing the accuracy of the Tet system might lead to effective gene therapy.
Gal Almogy, together with Gary Nolan associate professor at Stanford University, published a research report in the January 2009 issue of BioTechniques describing their improvements to the Tet system.
Almogy also discusses his career goals in the synthetic biology field and his desire to help students and post-docs navigate the academic job market.
Why Johnny Can't Clone: An interview with Dr. Ichiro Matsumura on his Practical Guide for best practices in molecular cloning
Reducing contamination in ancient DNA samples: An interview with Drs. Petra Korlević and Matthias Meyer
Antibody Validation | BenchTalk November 2013
Epigenetics Sept 2013 V2
The Translation Research Emphasis | BenchTalk, Episode 14
Behind the Scenes of GE's Cell Imaging Contest | BenchTalk, Episode 13